通过综合干预措施提高卵巢癌诊断后遗传咨询转诊率
该研究在单中心上皮性卵巢癌诊疗组中通过实践差距分析识别转诊障碍,开发包含转诊模板、遗传风险清单、家族史工作表及医患宣传的遗传咨询转诊工具包。历史队列81例(2013年7—12月)转诊率为48.1%(39/81),干预队列62例(2015年7—12月)转诊率为74.2%(46/62),差异有统计学意义(p=0.002)。转诊患者多数完成遗传咨询并选择基因检测。
要点
- 实施遗传咨询转诊工具包后,新诊断上皮性卵巢癌患者遗传咨询转诊率从48.1%升至74.2%(p=0.002)。
- 历史队列中未转诊者87.9%(29/33)完成咨询、79.3%(23/29)进行检测;干预队列60%(24/40)接受咨询、100%(24/24)完成检测。
- 作者结论认为质量改进流程创建的工具包提高了遗传咨询转诊率。
核心结论
- 应用质量改进流程创建遗传咨询转诊工具包提高了新诊断上皮性卵巢癌患者的遗传咨询转诊率。
- 多数被转诊患者完成了遗传咨询并选择基因检测。
研究设计与样本
- 单中心实践差距分析,比较历史队列与干预队列;历史队列为2013年7月至12月新诊断上皮性卵巢癌患者81例,干预队列为2015年7月至12月新诊断上皮性卵巢癌患者62例。
- 采用卡方检验、Fisher精确检验或t检验比较两组数据,采用单因素逻辑回归分析与转诊的关联。
主要发现
- 遗传咨询转诊率从2013年历史队列的48.1%(39/81)升至2015年干预队列的74.2%(46/62),p=0.002。
- 历史队列中无既往遗传咨询转诊记录的患者亚组,87.9%(29/33)完成咨询,79.3%(23/29)进行检测;干预队列中60%(24/40)接受咨询,100%(24/24)完成检测。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To increase genetic counseling referrals for patients with newly diagnosed epithelial ovarian cancer (EOC). METHODS: A practice-gap analysis was performed after measuring baseline genetic counseling referral rates to identify barriers to referral from the multidisciplinary single institution EOC care group. A Genetics Referral Toolkit consisting of a referral template, a genetic risk checklist, family history worksheet and provider and patient awareness was developed to address identified gaps with the goal of increasing referral rates. Clinical characteristics, referral placement, completion of genetic counseling/testing were abstracted for a historic cohort and intervention cohort. Data for the two cohorts were compared using chi-square, Fisher's exact test, or t-test. Association with referral was determined by univariate logistic regression. RESULTS: Eighty one patients from July through December 2013 (historic cohort) and 62 patients from July through December 2015 (intervention cohort) were identified as having a new diagnosis of EOC. Among these women, genetic counseling referral rates increased from 48.1% (39/81) in 2013 to 74.2% (46/62) in 2015 (p=0.002) after implementation of the toolkit. In a subset of patients without a previous genetic counseling referral, 87.9% (29/33) completed counseling and 79.3% (23/29) pursued testing from the historic cohort. In the intervention cohort, 60% (24/40) were seen for counseling and 100% (24/24) had testing. CONCLUSION: Application of a quality improvement process to create a Genetics Referral Toolkit increased the genetic counseling referral rate in patients with a new diagnosis of EOC. The majority of patients who were referred completed genetics consultation and elected genetic testing.
引用
- Swanson CL, Kumar A, Maharaj JM, et al. Increasing genetic counseling referral rates through bundled interventions after ovarian cancer diagnosis. Gynecol Oncol. 2018. PMID: 29402500. doi:10.1016/j.ygyno.2018.01.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。